Breaking News
Lieutenant General Leonard F. Anderson IV, commander of Marine Forces Reserve,...
Your bones are NOT supposed to get weaker as you age.
UBS has recently halted withdrawals from a $469 million real estate fund...
The Red Sea and the Strait of Hormuz have become the world's most critical digital chokepoints..
Top Tech News
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration
Hydrogen-powered business jet edges closer to certification
This House Is 10 Feet Underground and Costs $0 to Cool. Why Is It Banned in 30 States?
Cold Tolerant Lithium Battery?? Without Heaters!? Ecoworthy Cubix 100 Pro!
DLR Tests Hydrogen Fuel for Aviation at -253°C
Watch: China Claims Cyborg Breakthrough To Build An "Army Of Centaurs"
Instant, real-time video AI is now upon us, for better and worse
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
Single gene therapy injection surprisingly boosts vision in both eyes
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.